Comments
Unichem Laboratories’ formulations manufacturing facility at Ghaziabad has received an Establishment Inspection Report from the US Food and Drug Administration, indicating closure of inspection. The inspection was conducted by the USFDA in April, the company said in a notice to the stock exchanges. Shares of Unichem Laboratories closed at ₹232.90, down 2.69 per cent, on the NSE.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.